GL, Shunwei, Qiming et al Bolster Immunotherapy Tech
31 Jul 2024
US$ 19.00
GL Ventures has joined LTZ Therapeutics Inc’s (LTZ) existing investors Shunwei Capital, Qiming Venture Partners and K2 V...
Related Publications
Creaegis has led the US$45 million Series B funding round for subscription-based employee healthcare provider Onsurity...
The Longreach Group (Longreach) announced the final closing of Longreach Capital Partners 4 (Longreach 4) at ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.